Today

Agents

Chat

Arena

Discover

More

App

Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million - LYEL News | Rallies

Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million

LYEL•2026-08-06

Q2 operating expenses and income

Aug. 6 (Reuters) - Lyell Immunopharma Q2 operating income was USD -47.337 million.

Q2 adjusted net income was USD -40.622 million vs. IBES estimate USD -46.3 million
Q2 revenue was USD 4 thousand vs. IBES estimate USD 3.8 thousand

Related News

Canada's Parkit Enterprise Q2 FFO per share up on higher rent income

XLRE•2026-08-06

Navient 2Q FY26 GAAP net income rises 78.57% to $25 million; revenue slips 3.85% to $150 million

NAVI•2026-08-06

Reliance Global sells 251,666 shares to White Lion Capital for about $716,000

RELI

•

2026-08-06

Astrana Health Q2 2026 adjusted EPS more than doubles to $0.80; revenue rises 49% to $972.5 million vs year-ago quarter

ASTH•2026-08-06

JBT Marel declares quarterly dividend of $0.10 a share

JBTM•2026-08-06